News >

Technology Advances Aid Treatment Decisions for Community Oncologists

Ellie Leick
Published: Wednesday, Oct 02, 2019

Lori Brisbin, vice president of precision medicine at Texas Oncology

Lori Brisbin

Molecular testing has become an imperative step in the treatment decision-making process for oncologists, and new technologies and assays are emerging to further help identify tumor abnormalities and at the right time.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication